Clinical Trial Update: A Phase 2 Trial of High-Dose Ascorbate in Glioblastoma Multiforme [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating high-dose ascorbate (vitamin C) for glioblastoma multiforme is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma Multiforme

Drugs mentioned

• Ascorbate (high-dose vitamin C) (ascorbic acid)

Snippet

Sponsor: Bryan Allen | Conditions: Glioblastoma Multiforme | Phase 2 | Status: ACTIVE_NOT_RECRUITING